Suchergebnisse - "Nooka, Ajay K"

PubPharm (13)

1

Impact of Black Race on Peripheral Neuropathy in Patients With Newly Diagnosed Multiple Myeloma Receiving Bortezomib Induction

enthalten in: JCO oncology practice | 2023

von Sun, L. | Maples, K. | Hall, K. | +9

2

Carfilzomib 56 mg/m2 twice-weekly in combination with dexamethasone and daratumumab (KdD) versus daratumumab in combination with bortezomib and dexamethasone (DVd) : a matching-adjusted indirect treatment comparison

enthalten in: Leukemia & lymphoma | 2022

von Weisel, K. | Nooka, A. | Terpos, E. | +6

3

Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma

enthalten in: The New England journal of medicine | 2022

von Richardson, P. | Jacobus, S. | Weller, E. | +125

CommentIn: Expert Rev Hematol. 2023 Jul-Dec;16(8):561-563. - PMID 37334674

4

Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN

enthalten in: Blood cancer journal | 2022

von Nooka, A. | Kaufman, J. | Rodriguez, C. | +17

CommentIn: Future Oncol. 2022 Dec;18(40):4443-4456. - PMID 36799429

5

Phase 1 Trial Evaluating Vorinostat Plus Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma

enthalten in: Clinical lymphoma, myeloma & leukemia | 2020

von Kaufman, J. | Mina, R. | Shah, J. | +10

6

Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple Myeloma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2020

von Joseph, N. | Kaufman, J. | Dhodapkar, M. | +7

ErratumIn: J Clin Oncol. 2020 Aug 10;38(23):2702. - PMID 32755511

7

Daratumumab-based regimens are highly effective and well tolerated in relapsed or refractory multiple myeloma regardless of patient age : subgroup analysis of the phase 3 CASTOR and POLLUX studies

enthalten in: Haematologica | 2020

von Mateos, M. | Spencer, A. | Nooka, A. | +16

8

Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone

enthalten in: Blood cancer journal | 2019

von Schmidt, T. | Barwick, B. | Joseph, N. | +13

9

Clinical efficacy of daratumumab, pomalidomide, and dexamethasone in patients with relapsed or refractory myeloma : Utility of re-treatment with daratumumab among refractory patients

enthalten in: Cancer | 2019

von Nooka, A. | Joseph, N. | Kaufman, J. | +5

CommentIn: Cancer. 2019 Sep 1;125(17):2920-2922. - PMID 31090923

10

Multiple myeloma immunoglobulin lambda translocations portend poor prognosis

enthalten in: Nature communications | 2019

von Barwick, B. | Neri, P. | Bahlis, N. | +11